Republican election group targets John Salazar over health care vote
Republicans are tightening the pressure on U.S. Rep. John Salazar, D-Colo., trying to turn around his yes vote on the House health care measure.
The National Republican Congressional Committee started making “code-red alert” robo-calls Thursday to voters in Salazar’s 3rd Congressional District, which includes most of the Western Slope.
Salazar’s office described the National Republican Congressional Committee as “an extreme partisan operation” and said he declined comment on the calls.
In the calls, a woman’s voice says the call is from the NRCC about the impending health care vote in Congress. The call goes on to say:
“Even though a majority of Colorado voters want them to scrap it, Speaker Nancy Pelosi and President Obama are planning to ram their dangerous, out-of-control health care spending bill through Congress anyway. What’s worse, Congressman John Salazar voted for this bill the last time it was up and might vote for it again. Salazar already voted for a bill that will kill jobs, raise the costs of health care and increase taxes. John Salazar should be focusing on creating jobs, yet he might be the deciding vote that causes this massive new spending bill to pass. Please call John Salazar now at 202-225-4761 before it is too late and tell him to vote ‘no’ on Nancy Pelosi’s dangerous health care scheme. Visit http://www.nrcc.org/codered to learn more. This call was paid for by the National Republican Congressional Committee and not authorized by any candidate or candidate’s committee, 202-479-7000.”
Salazar, who is running for his fourth term this year, voted for the House bill, which contained a public option that he said would offer coverage much like that offered at the Marillac Clinic, which offers health care to the uninsured.
The House bill also includes safeguards against using public money for abortions, a provision that is absent from the Senate measure that some expect to be approved by the House.
Salazar is a sponsor of a stand-alone health care measure that would allow the Department of Health and Human Services to negotiate prices with pharmaceutical companies.